These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 17700049

  • 21. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression.
    Koch JM, Hinze-Selch D, Stingele K, Huchzermeier C, Goder R, Seeck-Hirschner M, Aldenhoff JB.
    Psychother Psychosom; 2009; 78(3):187-92. PubMed ID: 19321972
    [Abstract] [Full Text] [Related]

  • 22. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS, Ng F, Berk M.
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [Abstract] [Full Text] [Related]

  • 23. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
    Van HL, Dekker J, Peen J, van Aalst G, Schoevers RA.
    Psychother Psychosom; 2008 Apr; 77(6):358-64. PubMed ID: 18701832
    [Abstract] [Full Text] [Related]

  • 24. [Is interpersonal psychotherapy a woman specific method? Results of a randomized controlled study].
    Schneider D, Zobel I, Härter M, Kech S, Berger M, Schramm E.
    Psychother Psychosom Med Psychol; 2008 Jan; 58(1):23-31. PubMed ID: 17659490
    [Abstract] [Full Text] [Related]

  • 25. The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
    Manber R, Rush AJ, Thase ME, Amow B, Klein D, Trivedi MH, Korenstein SG, Markowitz JC, Dunner DL, Munsaka M, Borian FE, Martin, Keller B.
    Sleep; 2003 Mar 15; 26(2):130-6. PubMed ID: 12683470
    [Abstract] [Full Text] [Related]

  • 26. A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression.
    Perahia DG, Quail D, Gandhi P, Walker DJ, Peveler RC.
    J Affect Disord; 2008 May 15; 108(1-2):33-41. PubMed ID: 17905442
    [Abstract] [Full Text] [Related]

  • 27. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.
    Eur Neuropsychopharmacol; 2009 Jul 15; 19(7):457-65. PubMed ID: 19345072
    [Abstract] [Full Text] [Related]

  • 28. Cognitive Behavioral Analysis System of Psychotherapy versus Escitalopram in Chronic Major Depression.
    Schramm E, Zobel I, Schoepf D, Fangmeier T, Schnell K, Walter H, Drost S, Schmidt P, Brakemeier EL, Berger M, Normann C.
    Psychother Psychosom; 2015 Jul 15; 84(4):227-40. PubMed ID: 26022410
    [Abstract] [Full Text] [Related]

  • 29. [Treatment of depressive disorder and comorbid personality pathology: combined therapy versus pharmacotherapy].
    Kool S, Schoevers R, Duijsens IJ, Peen J, van Aalst G, de Jonghe F, Dekker J.
    Tijdschr Psychiatr; 2007 Jul 15; 49(6):361-72. PubMed ID: 17611937
    [Abstract] [Full Text] [Related]

  • 30. Sleep in major depression: relation to memory performance and outcome after interpersonal psychotherapy.
    Goder R, Fritzer G, Hinze-Selch D, Huchzermeier C, Koch JM, Seeck-Hirschner M, Aldenhoff JB.
    Neuropsychobiology; 2007 Jul 15; 55(1):36-42. PubMed ID: 17556851
    [Abstract] [Full Text] [Related]

  • 31. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
    Schatzberg AF, Rush AJ, Arnow BA, Banks PL, Blalock JA, Borian FE, Howland R, Klein DN, Kocsis JH, Kornstein SG, Manber R, Markowitz JC, Miller I, Ninan PT, Rothbaum BO, Thase ME, Trivedi MH, Keller MB.
    Arch Gen Psychiatry; 2005 May 15; 62(5):513-20. PubMed ID: 15867104
    [Abstract] [Full Text] [Related]

  • 32. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ, Trivedi MH, Rush AJ, Thase ME, Howland R, Klein DN, Kornstein SG, Dunner DL, Markowitz JC, Hirschfeld RM, Keitner GI, Zajecka J, Kocsis JH, Russell JM, Miller I, Manber R, Arnow B, Rothbaum B, Munsaka M, Banks P, Borian FE, Keller MB.
    Biol Psychiatry; 2003 Oct 15; 54(8):806-17. PubMed ID: 14550680
    [Abstract] [Full Text] [Related]

  • 33. Does adding psychotherapy to pharmacotherapy improve social functioning in the treatment of outpatient depression?
    Molenaar PJ, Dekker J, Van R, Hendriksen M, Vink A, Schoevers RA.
    Depress Anxiety; 2007 Oct 15; 24(8):553-62. PubMed ID: 17131302
    [Abstract] [Full Text] [Related]

  • 34. Randomized trial on the effectiveness of long-and short-term psychodynamic psychotherapy and solution-focused therapy on psychiatric symptoms during a 3-year follow-up.
    Knekt P, Lindfors O, Härkänen T, Välikoski M, Virtala E, Laaksonen MA, Marttunen M, Kaipainen M, Renlund C, Helsinki Psychotherapy Study Group.
    Psychol Med; 2008 May 15; 38(5):689-703. PubMed ID: 18005493
    [Abstract] [Full Text] [Related]

  • 35. Cost-effectiveness of interpersonal psychotherapy for elderly primary care patients with major depression.
    Bosmans JE, van Schaik DJ, Heymans MW, van Marwijk HW, van Hout HP, de Bruijne MC.
    Int J Technol Assess Health Care; 2007 May 15; 23(4):480-7. PubMed ID: 17937837
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients.
    Higuchi H, Sato K, Yoshida K, Takahashi H, Kamata M, Otani K, Yamaguchi N.
    Psychiatry Clin Neurosci; 2008 Jun 15; 62(3):301-6. PubMed ID: 18588590
    [Abstract] [Full Text] [Related]

  • 38. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K, Chrzanowski W, Schmitz M, Savela A, Milanova V, Gee M, Krishen A, Millen L, Leary MO, Modell J.
    J Psychopharmacol; 2009 Jul 15; 23(5):531-8. PubMed ID: 18635695
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A, Pluck G, Eranti SV, Landau S, Purvis R, Brown RG, Curtis V, Howard R, Philpot M, McLoughlin DM.
    Psychol Med; 2008 Mar 15; 38(3):323-33. PubMed ID: 17935639
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.